Evaluation of Commercial SARS-CoV-2 Antibody Immunoassays for COVID-19
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 70
- 试验地点
- 1
- 主要终点
- The accuracy of the different commercial SARS-CoV-2 antibody immunoassays
研究概览
简要总结
Achieved serum samples of persons with or without evidence of COVID-19 infection are tested using the different commercial SARS-CoV-2 antibody immunoassays. The performance of the immunoassays is then assessed by comparing the 2 groups of samples.
详细描述
Achieved serum samples of the different testing groups are retrieved and tested with the immunoassays according to manufacturer's instruction.
The test results are then compared and analyzed with statistical tests to assess the immunoassays'performance
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
结局指标
主要结局
The accuracy of the different commercial SARS-CoV-2 antibody immunoassays
时间窗: 1 month
To investigate the accuracy (including sensitivity, specificity, positive and negative predictive value) of the commercial SARS-CoV-2 antibody immunoassays
次要结局
未报告次要终点
研究者
Dr. Jonpaul ST Zee
Specialist in Infectious Disease
Hong Kong Sanatorium & Hospital